Back to Results

Iris Acquisition II Corp Unit (IRAB_u)

Iris Acquisition II Corp Unit (IRAB.U) is a listed debt/equity composite unit on the NYSE. The security is associated with Iris Acquisition II Corp, a special purpose acquisition company formed to pursue a business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more businesses. The issuer was incorporated in 2025 and is based in Dubai, United Arab Emirates. As a unit, the instrument represents a hybrid listed security rather than ordinary common equity.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-IRAB.U
—
—
—
—
—
—
Good
—
—
—
0.0%
August 13, 2026
-1,673.5x
—
—
227.9 M
226.9 M
0.0%
69.6%
—
—
0.0%
Send a message
Valuation • Fair Value

Iris Acquisition II Corp Unit (NYSE-IRAB.U) Fair Value by Valuation Model

Compare the primary fair value estimate for Iris Acquisition II Corp Unit (NYSE-IRAB.U) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Iris Acquisition II Corp Unit (NYSE-IRAB.U) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Iris Acquisition II Corp Unit (NYSE-IRAB.U) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

0

Weak quality score that deserves closer review.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

0.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Iris Acquisition II Corp Unit (NYSE-IRAB.U). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 13, 2026

Days to Earnings

23

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Iris Acquisition II Corp Unit (NYSE-IRAB.U), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Iris Acquisition II Corp Unit (NYSE-IRAB.U) Stock Forecast & Technical Outlook

Review Iris Acquisition II Corp Unit (NYSE-IRAB.U) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Iris Acquisition II Corp Unit (NYSE-IRAB.U) Stock FAQ

Quick answers about Iris Acquisition II Corp Unit (NYSE-IRAB.U) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

A fair value estimate for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

An analyst price target for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is not currently available in the latest data file.

The current financial health read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is August 13, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is -1,673.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Iris Acquisition II Corp Unit is 227.9 M.

The current enterprise value listed for Iris Acquisition II Corp Unit is 226.9 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Iris Acquisition II Corp Unit is NYSE-IRAB.U, and the stock is listed on NYSE.

Iris Acquisition II Corp Unit (NYSE-IRAB.U) is listed on NYSE.

The current debt-to-total-capital ratio listed for Iris Acquisition II Corp Unit is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Iris Acquisition II Corp Unit is 69.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Capital Markets Stocks on NYSE View more

Morgan Stanley (MS) Morgan Stanley (MS)
Morgan Stanley Pa ADR (MS_pa) Morgan Stanley Pa ADR (MS_pa)
Morgan Stanley Pe ADR (MS_pe) Morgan Stanley Pe ADR (MS_pe)
Morgan Stanley Pf ADR (MS_pf) Morgan Stanley Pf ADR (MS_pf)
Morgan Stanley Pi ADR (MS_pi) Morgan Stanley Pi ADR (MS_pi)
Morgan Stanley Pref K (MS_pk) Morgan Stanley Pref K (MS_pk)
Goldman Sachs Group Inc (GS) Goldman Sachs Group Inc (GS)
Goldman Sachs Group Inc Pa ADR (GS_pa) Goldman Sachs Group Inc Pa ADR (GS_pa)
Goldman Sachs Group Inc Pc ADR (GS_pc) Goldman Sachs Group Inc Pc ADR (GS_pc)
Goldman Sachs Group Inc Pd ADR (GS_pd) Goldman Sachs Group Inc Pd ADR (GS_pd)
Charles Schwab Corp (SCHW) Charles Schwab Corp (SCHW)
BlackRock Inc (BLK) BlackRock Inc (BLK)
UBS Group AG (UBS) UBS Group AG (UBS)
Blackstone Inc (BX) Blackstone Inc (BX)
S&P Global Inc (SPGI) S&P Global Inc (SPGI)
Bank of New York Mellon Corp (BNY) Bank of New York Mellon Corp (BNY)
Brookfield Corp (BN) Brookfield Corp (BN)
Moodys Corporation (MCO) Moodys Corporation (MCO)
KKR & Co Inc Preferred (KKR_pd) KKR & Co Inc Preferred (KKR_pd)
KKR & Co LP (KKR) KKR & Co LP (KKR)
Intercontinental Exchange Inc (ICE) Intercontinental Exchange Inc (ICE)
Brookfield Asset Management Inc (BAM) Brookfield Asset Management Inc (BAM)
Deutsche Bank AG NA O.N. (DB) Deutsche Bank AG NA O.N. (DB)
State Street Corp (STT) State Street Corp (STT)